FRI155 Effect Of Reversal Of Renin Suppression On Renal Outcome In Medically Treated Primary Aldosteronism

Disclosure: Y. Tsurutani: None. S. Katsuragawa: None. K. Inoue: None. K. Nakai: None. J. Saito: None. T. Nishikawa: None. A. Goto: None. Background and Objective: In the strategy of medical treatment with mineralocorticoid receptor antagonist (MRA) for primary aldosteronism (PA), achieving reversal...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsurutani, Yuya, Katsuragawa, Sho, Inoue, Kosuke, Nakai, Kazuki, Saito, Jun, Nishikawa, Tetsuo, Goto, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Cardiovascular Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554987/
http://dx.doi.org/10.1210/jendso/bvad114.667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554987/
http://dx.doi.org/10.1210/jendso/bvad114.667

Ejemplares similares